Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China · Delayed Price · Currency is CNY 17.31
+0.56 (3.34%)
Jan 23, 2026, 12:39 PM CST
SHE:300497 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -272.78 | -272.1 | -200.8 | -141.47 | 48.83 | 319.3 | Upgrade |
Depreciation & Amortization | 170.72 | 170.72 | 159.46 | 123.84 | 98.57 | 73.93 | Upgrade |
Other Amortization | 0.37 | 0.37 | - | - | 1.13 | 1.25 | Upgrade |
Loss (Gain) From Sale of Assets | 0.1 | 0.1 | -0.08 | -0.41 | 0.06 | -1.02 | Upgrade |
Asset Writedown & Restructuring Costs | 101.63 | 101.63 | 24.88 | 13.89 | 5.93 | 12.39 | Upgrade |
Loss (Gain) From Sale of Investments | 15.52 | 15.52 | 16.19 | 1.44 | 47.94 | 15.56 | Upgrade |
Provision & Write-off of Bad Debts | -0.87 | -0.87 | 0.91 | 0.79 | - | - | Upgrade |
Other Operating Activities | -35.19 | 85.6 | 49 | 178.9 | 96.84 | 35.22 | Upgrade |
Change in Accounts Receivable | 13.09 | 13.09 | -159.45 | -273.95 | -199.39 | -152.73 | Upgrade |
Change in Inventory | -44.8 | -44.8 | 74.55 | -259.58 | -154.85 | -52.37 | Upgrade |
Change in Accounts Payable | 128.91 | 128.91 | -33.38 | 232.27 | 139.1 | 135.39 | Upgrade |
Change in Other Net Operating Assets | - | - | 7.03 | 1.66 | 6.32 | -0.78 | Upgrade |
Operating Cash Flow | 66.17 | 187.64 | -64.76 | -120.85 | 72.32 | 382.35 | Upgrade |
Operating Cash Flow Growth | -35.23% | - | - | - | -81.08% | 13.15% | Upgrade |
Capital Expenditures | -212.19 | -141.75 | -242.23 | -459.41 | -679.6 | -449.24 | Upgrade |
Sale of Property, Plant & Equipment | 0.95 | 1.1 | 1.61 | 3.81 | 0.3 | 7.89 | Upgrade |
Investment in Securities | 9.32 | - | -114.72 | -53.6 | -73.25 | -108.12 | Upgrade |
Other Investing Activities | 1.17 | 1.04 | 0.83 | 0.87 | 17.06 | 0.97 | Upgrade |
Investing Cash Flow | -200.75 | -139.61 | -354.5 | -508.34 | -735.48 | -548.5 | Upgrade |
Long-Term Debt Issued | - | 641 | 956.44 | 1,241 | 1,048 | 597 | Upgrade |
Long-Term Debt Repaid | - | -658.78 | -729.98 | -830.49 | -488.5 | -596.5 | Upgrade |
Net Debt Issued (Repaid) | 73.22 | -17.78 | 226.47 | 410.51 | 559.11 | 0.5 | Upgrade |
Issuance of Common Stock | - | - | - | - | 34.79 | 994.15 | Upgrade |
Repurchase of Common Stock | -18 | -18 | - | -69.75 | -105.11 | - | Upgrade |
Common Dividends Paid | -53.69 | -55.5 | -55.79 | -54.58 | -139.18 | -81.9 | Upgrade |
Other Financing Activities | 81.06 | 3.5 | -20.91 | -3.2 | - | -0.06 | Upgrade |
Financing Cash Flow | 82.59 | -87.78 | 149.76 | 282.99 | 349.61 | 912.69 | Upgrade |
Foreign Exchange Rate Adjustments | 4.76 | 7.83 | 3 | 9.51 | 0.74 | -8.6 | Upgrade |
Net Cash Flow | -47.23 | -31.92 | -266.5 | -336.69 | -312.81 | 737.94 | Upgrade |
Free Cash Flow | -146.02 | 45.89 | -306.99 | -580.26 | -607.28 | -66.89 | Upgrade |
Free Cash Flow Margin | -15.05% | 3.90% | -19.07% | -35.23% | -42.48% | -4.48% | Upgrade |
Free Cash Flow Per Share | -0.27 | 0.09 | -0.57 | -1.07 | -1.12 | -0.14 | Upgrade |
Cash Income Tax Paid | - | -98.69 | -15.84 | -54.01 | 19.34 | 55.87 | Upgrade |
Levered Free Cash Flow | -199.22 | 66.66 | -379.88 | -536.77 | -490.78 | -63.61 | Upgrade |
Unlevered Free Cash Flow | -174.32 | 92.02 | -353.61 | -511.08 | -475.2 | -48.77 | Upgrade |
Change in Working Capital | 89.04 | 89.04 | -115.96 | -300.32 | -226.98 | -74.28 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.